Prurigo pigmentosa
Prurigo pigmentosa rewşek çermî ya nadir e ku sedemêk nediyar e, ku bi destpêka nîşanê ve papulên erythematoz ên ku gava sax dibin, hîperpîgmentasyona retîkuler dîhêlin, diyar dibe. Rewş carinan ji ber sînordarkirina parêzêkê vê dawîyê çêdibe.
☆ AI Dermatology — Free Service
Di encamên 2022-an de Stiftung Warentest ji Almanyayê, razîbûna xerîdar bi ModelDerm tenê ji şêwirmendên telemedicine drav hindik hindiktir bû.
Di encamên 2022-an de Stiftung Warentest ji Almanyayê, razîbûna xerîdar bi ModelDerm tenê ji şêwirmendên telemedicine drav hindik hindiktir bû.
relevance score : -100.0%
ReferencesPrurigo pigmentosa rewşek çermî a inflamatuar a nadir e ku yekem car ji hêla Nagashima et al ve di sala 1971‑an de hatî vegotin. Ew bi giranî bandorê li jinên ciwan ên bi eslê xwe Asyayê Rojhilat dike, lê dikare li yên din jî çêbibe. Ew wek pişkek sîmetrîk a kulên sor ên bilindkirî li ser stû, sîng û piştê xuya dike. Van gemaran bi gelemperî nexşeyek mîna torê çêdikin û dikarin werin û biçin; li ser çerm pişkên tarîtir bihêlin. Prurigo pigmentosa dikare ji hêla guhartinên metabolîzmê ve were rêve kirin, mîna yên ku ji hêla parêzên ketogenîk ve têne çêkirin, ku di van demên dawî de popûlertir bûne.
Prurigo pigmentosa, also known as Nagashima disease or keto rash, is a rare inflammatory skin disease initially described by Nagashima et al in 1971. Prurigo pigmentosa typically, but not exclusively, affects young females of East Asian ethnicity, presenting as a symmetrical eruption of urticarial papules on the neck, chest, and back. The papular eruption typically coalesces into a reticulated pattern that repeatedly resolves and recurs, resulting in hyperpigmented skin of cosmetic concern. Prurigo pigmentosa can be triggered by metabolic derangements, including those secondary to ketogenic diets, which have experienced a rise in popularity in recent years.
Prurigo pigmentosa, also known as Nagashima disease or keto rash, is a rare inflammatory skin disease initially described by Nagashima et al in 1971. Prurigo pigmentosa typically, but not exclusively, affects young females of East Asian ethnicity, presenting as a symmetrical eruption of urticarial papules on the neck, chest, and back. The papular eruption typically coalesces into a reticulated pattern that repeatedly resolves and recurs, resulting in hyperpigmented skin of cosmetic concern. Prurigo pigmentosa can be triggered by metabolic derangements, including those secondary to ketogenic diets, which have experienced a rise in popularity in recent years.
Prurigo pigmentosa rewşek çermî ye ku ji nişka ve, bi xiş û sor, bi şêweyek torî û li dû deqên tarî çêdibe. Di demên dawî de, hin delîl hatine damezrandin ku Prurigo pigmentosa bi parêzê ketogenîk ve girêdayî ye. Ew dikare li mirovên ji temen û zayendên cûda bandor bike, bi meylê ku di jinan de zêdetir be. Di rewşên ku vegerandina parêzek birêkûpêk an karanîna dermanên çermî bi tevahî alîkariyê nade, bijîjk dikare qursê antîbiyotîkên devkî yên wekî doxycycline an minocycline (100 mg du caran rojê, du caran ji bo 1 heta 2 mehan) destnîşan bike.
Prurigo pigmentosa is a skin condition causing sudden, itchy, red bumps in a net-like pattern followed by dark spots. Lately, some evidences were founded that Prurigo pigmentosa is associated with the ketogenic diet. It can affect people of different ages and genders, with a tendency to be more common in females. In cases where returning to a regular diet or using skin treatments doesn't fully help, doctors may prescribe a course of oral antibiotics like doxycycline or minocycline (100 mg twice daily for 1 to 2 months).
Prurigo pigmentosa is a skin condition causing sudden, itchy, red bumps in a net-like pattern followed by dark spots. Lately, some evidences were founded that Prurigo pigmentosa is associated with the ketogenic diet. It can affect people of different ages and genders, with a tendency to be more common in females. In cases where returning to a regular diet or using skin treatments doesn't fully help, doctors may prescribe a course of oral antibiotics like doxycycline or minocycline (100 mg twice daily for 1 to 2 months).
